AMGN has been in the news 409% more than usual
Feb 13, 2026, 11:32 PM
-0.76%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: On 13 February 2026 Amgen announced EU approval of UPLIZNA, the first CD19‑targeted therapy for adults with generalized myasthenia gravis who are anti‑AChR‑ or anti‑MuSK‑antibody positive. UPLIZNA is dosed as two initial loading injections followed by maintenance dosing twice yearly.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.